Adherium

Norah, age 10, from Western Park in Leicester is one of the first children recruited to the NHS funded study of the Hailie® digital inhaler. She has struggled with asthma since being diagnosed at age 5. Mum Hayley comments: “I’m really pleased that Norah is on this trial as I want it to help her while also benefitting other children with asthma who may get Smart Inhalers in the future, if this trial is successful. Norah is such a sporty little girl, who is so full of life. I never want asthma to hold her back.”   Find out more here 👉 https://lnkd.in/gFq_HvmA #asthma #respiratoryhealth #realworldstudy #asthmaawareness #asthmatreatment #asthmamanagement #inhaler #digitalhealth #ehealth #medtech

This weekend, #Adherium CEO Paul Mastoridis, Pharm.D. had the privilege of addressing Allergy Partners PLLC – the largest allergy group in the US. His presentation focused on how Adherium's Digital Adherence Program can make a meaningful difference for allergy sufferers nationwide. By combining smart inhaler technology with personalised support, our program is designed to help patients master the correct inhaler technique and adhere to their medication plans. This not only leads to improved symptom management and quality of life, but also has the potential to reduce exacerbations, emergency room visits and hospitalizations. We believe in empowering patients to take control of their respiratory health, and this collaboration with Allergy Partners is a significant step towards making that a reality for more people. We are excited about the possibilities ahead and remain committed to our mission of improving patient outcomes through innovative technology and support. $ADR #Adherium #digitalhealth #respiratoryhealth #patienthealth #innovation #patientcare #ehealth #asthma #COPD #healthcare

🤝 New Partnership   #Adherium is pleased to announce that it has secured a landmark partnership with Valued Relationships Inc. (VRI), a Modivcare service and leading provider of personalized healthcare services.      The collaboration will see Adherium’s Hailie® technology integrated into VRI’s member care protocols, reaching a member base of over 2.5 million annual person-to-person interactions, and active monitoring of over 155,000 members.    Adherium CEO, Dr. Paul Mastoridis, commented:     “Our alliance with VRI is a testament to Adherium’s commitment to harnessing innovative technology to enhance member care. We are poised to improve the lives of those affected by asthma and COPD by reducing exacerbations, emergency room visits, and hospitalizations, ultimately elevating the quality of life for members.”    Read the ASX release 👉 https://bit.ly/ADR-VRI     $ADR #Adherium #digitalhealth #ehealth #asthma #COPD #inhalers #smartinhaler #respiratoryhealth #medtech  

Dr Erol Gaillard at the University of Leicester and University Hospitals of Leicester NHS Trust is leading a new NHS funded study of Adherium’s Hailie® digital inhaler. The study in Leicester will find out whether the use of Hailie® will prevent children aged 5-16 with high-risk asthma from having flare-ups (or asthma attacks), which put 21,000 children in the UK into A&E each year. Find out more here 👉 https://lnkd.in/gFq_HvmA #asthma #respiratoryhealth #realworldstudy #asthmaawareness #asthmatreatment #asthmamanagement #inhaler #digitalhealth #ehealth #medtech

Thanks to Clinical Trials Arena for sharing the news of this important new study of Adherium’s Hailie® SmartInhaler® technology , which could pave the way for new standard-of-care in asthma treatment. Read the article 👉 https://lnkd.in/gMYtGgwp #asthma  #respiratoryhealth #realworldstudy #asthmaawareness #asthmatreatment #asthmamanagement #inhaler #digitalhealth #ehealth #medtech

📰 In The News This week marks the launch of a new NHS funded study of the Hailie® digital inhaler in in Leicester, UK. Thanks to BBC News for sharing the news and highlighting the potential of our Hailie® Smart Inhaler® technology in reducing asthma deaths and hospitalisations. Here’s an excerpt: “Dr Gaillard said if the technology could be refined and rolled out widely across the NHS, he thinks "it will have a big impact on asthma control, asthma attacks and even asthma deaths". He added: "Deaths are often caused by patients not taking their preventer steroid medication and over-using their blue rescue inhaler, so therefore if we can track patients use of the correct medication, I think this could prevent asthma deaths and hospitalisations." Take a look 👉 https://bit.ly/ADR-BBC #asthma  #respiratoryhealth  #realworldstudy #asthmaawareness #asthmatreatment #asthmamanagement #inhaler #digitalhealth #ehealth #medtech

🎉 We’re thrilled to share some groundbreaking news! 🎉 Adherium is on the brink of a medical revolution with the launch of an NHS-funded study in Leicester, UK, featuring the innovative Hailie® digital inhaler. This isn’t just any study; it’s a potential game-changer in the world of asthma care. Imagine a world where high-risk asthma attacks in children are a thing of the past. That’s the future we’re aiming for with Hailie®. Our goal? To shield 21,000 children in the UK from the frightening rush to A&E every year due to asthma flare-ups. But wait, there’s more! For the first time ever in the UK, we’re harnessing the power of technology to sift through GP records systematically, identifying children and young people at high risk who could benefit from a Smart Inhaler. If we hit the mark with this study, we could be looking at a new standard of care—a beacon of hope for asthma management across the NHS. Stay tuned as we embark on this exciting journey with Hailie®, where every breath counts, and every success brings us closer to a world where asthma is no longer a barrier to living life to the fullest. Let’s breathe easier, together! 💨✨

Adherium Europe Ltd is proud to announce that a new NHS funded study of the Hailie® digital inhaler has begun in Leicester, UK. The study will find out whether the use of Hailie® will prevent children aged 5-16 with high-risk asthma from having flare-ups (or asthma attacks), which put 21,000 children in the UK into A&E each year.   This is the first time that a UK study will identify high-risk children and young people who could benefit from a Smart Inhaler from a systematic search of GP records, and if the study is successful, could pave the way for its wider adoption across the NHS. The study is led by Dr Erol Gaillard at the University of Leicester. Helicon Health Ltd will deploy and support the University team with Adherium’s Hailie® digital inhalers. The study is backed by the Leicester, Leicestershire and Rutland Integrated Care Board, the Asthma UK Centre for Applied Research Patient and Public Involvement group, Health Innovation East Midlands and Asthma + Lung UK, and has received funding of £499,871 from the Small Business Research Initiative Healthcare (SBRI Healthcare), an Accelerated Access Collaborative Initiative. Find out more here 👉 https://lnkd.in/gFq_HvmA #asthma #respiratoryhealth #realworldstudy #asthmaawareness #asthmatreatment #asthmamanagement #inhaler #digitalhealth #ehealth #medtech

Adherium is pleased to announce that AstraZeneca has selected its Hailie® Smartinhaler® platform for a clinical trial. This contract is valued at $1.1M over the course of the study.    Adherium CEO, Dr. Paul Mastoridis, said:     “This agreement underscores Adherium's strategic commitment to enhancing patient care through advanced technology. Our Hailie® platform is designed to ensure precise monitoring and support for patients with respiratory diseases, facilitating the pursuit of tailored therapy."    Adherium will be providing its Hailie® Smartinhalers®, Hailie® app and Platform for the trial, supporting accurate tracking of inhaler medication use through the selected eCOA (Electronic Clinical Outcome Assessment) devices.     Read the ASX release 👉 https://lnkd.in/gYAxayhz     $ADR #Adherium #inhalers #ehealth #digitalhealth #respiratoryhealth #asthma #COPD 

Greetings from San Diego  👋   Members of Adherium’s Executive Team are currently on the ground at the 2024 American Thoracic Society (ATS) International Conference, together with more than 14,000 pulmonary, critical care, and sleep health professionals too.   Pictured here, our CEO Dr. Paul Mastoridis, Pharm.D., is actively discussing the capabilities of Adherium’s Hailie® Smartinhaler® technology and cloud-based data collection portal –market-leading technology, which is on track to radically improve medication adherence in the treatment of #asthma and #COPD.   Say hello, we’re keen to share the good news!   #ADR #Adherium #ehealth #digitalhealth #respiratoryhealth #inhalers #asthma #COPD #ATS2024